Abstract
In this study a square - wave voltammetric method was developed and validated for the direct determination of glimepiride in bulk form and pharmaceutical formulations. The best results were obtained for the quantitative determination of glimepiride in 0.04 M Britton - Robinson buffer at pH 9.0 at -1160 mV vs. Ag/AgCl reference electrode. The experimental and instrumental parameters affecting the peak current of glimepiride were investigated and optimized. The electrochemical behavior of glimepiride was also investigated by cyclic voltammetry. The monitored peak current was directly proportional to the concentration of glimepiride and it shows a linear response in the range from 0.25 - 7.81 μg mL-1 (r = 0.9998). The accuracy of the proposed method was indicated via the mean recovery of 100.95 ± 0.61 % with RSD of 1.48 % at a concentration level of 4.89 μg mL-1. After validation of the proposed method, the applicability of this voltammetric method was carried out by the determination of glimepiride in its pharmaceutical formulations. Possible interferences by several substances usually present in the pharmaceutical formulations have been also evaluated. No interferences were observed. The results obtained from the developed voltammetric method were compared with those obtained by the reported analytical method in the literature.
Keywords: Glimepiride, Square - wave voltammetry, Quantification, Optimization, Validation, Pharmaceutical formulations, Britton - Robinson buffer, Accuracy, Derivate spectrophotometry, HPLC - tandem mass spectrometry
Current Analytical Chemistry
Title: Determination of Glimepiride in Pharmaceutical Formulations by Square-Wave Voltammetric Method
Volume: 7 Issue: 4
Author(s): Incilay Suslu and Sacide Altinoz
Affiliation:
Keywords: Glimepiride, Square - wave voltammetry, Quantification, Optimization, Validation, Pharmaceutical formulations, Britton - Robinson buffer, Accuracy, Derivate spectrophotometry, HPLC - tandem mass spectrometry
Abstract: In this study a square - wave voltammetric method was developed and validated for the direct determination of glimepiride in bulk form and pharmaceutical formulations. The best results were obtained for the quantitative determination of glimepiride in 0.04 M Britton - Robinson buffer at pH 9.0 at -1160 mV vs. Ag/AgCl reference electrode. The experimental and instrumental parameters affecting the peak current of glimepiride were investigated and optimized. The electrochemical behavior of glimepiride was also investigated by cyclic voltammetry. The monitored peak current was directly proportional to the concentration of glimepiride and it shows a linear response in the range from 0.25 - 7.81 μg mL-1 (r = 0.9998). The accuracy of the proposed method was indicated via the mean recovery of 100.95 ± 0.61 % with RSD of 1.48 % at a concentration level of 4.89 μg mL-1. After validation of the proposed method, the applicability of this voltammetric method was carried out by the determination of glimepiride in its pharmaceutical formulations. Possible interferences by several substances usually present in the pharmaceutical formulations have been also evaluated. No interferences were observed. The results obtained from the developed voltammetric method were compared with those obtained by the reported analytical method in the literature.
Export Options
About this article
Cite this article as:
Suslu Incilay and Altinoz Sacide, Determination of Glimepiride in Pharmaceutical Formulations by Square-Wave Voltammetric Method, Current Analytical Chemistry 2011; 7 (4) . https://dx.doi.org/10.2174/157341111797183056
DOI https://dx.doi.org/10.2174/157341111797183056 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Advances in Microfluidic and Sensing Technologies of Biofluids.
Detection of biological fluids is an important means to assess human health and diagnose diseases. Currently, research on blood is relatively mature and widely applied in the medical field. With the development and advancement of microfluidic technology and novel detection methods, attention has turned to human physiological fluids such as ...read more
Analytical methods for environmental and food analysis
In recent years, the study of the chemical composition of food and the environment depends on analytical methods in order to acquire information about the chemical composition, processing, quality control and contamination of soil, water, air, plants and foods, aspects very important for food safety and environmental quality control. There ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glutamate-Mediated Signaling and Autism Spectrum Disorders: Emerging Treatment Targets
Current Pharmaceutical Design The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
Current Medicinal Chemistry Phycobilins and Phycobiliproteins Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Patent Selections
Recent Patents on Food, Nutrition & Agriculture Is There any Correlation Between Diabetic Retinopathy and Risk of Cardiovascular Disease?
Current Diabetes Reviews Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach
Current Neuropharmacology Increased Susceptibility to Plasma Lipid Peroxidation in Alzheimer Disease Patients
Current Alzheimer Research Endocannabinoid System: Emerging Role from Neurodevelopment to Neurodegeneration
Mini-Reviews in Medicinal Chemistry Schiff Bases of Istain: Antiglycation Activity
Letters in Drug Design & Discovery Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers
Current Alzheimer Research Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia
Current Pharmaceutical Design Gene Therapy Strategies to Prevent Autoimmune Disorders
Current Gene Therapy Aldose Reductase: A Multi-disease Target
Current Enzyme Inhibition Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries
CNS & Neurological Disorders - Drug Targets Current Strategies and Future Perspective for the Effective Treatment of Diabetic Retinopathy
Current Drug Therapy Endothelial Dysfunction in Cardiac Allograft Vasculopathy: Potential Pharmacological Interventions
Current Vascular Pharmacology Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease
Letters in Drug Design & Discovery Antioxidants in Treating Pathologies Involving Oxidative Damage: An Update on Medicinal Chemistry and Biological Activity of Stobadine and Related Pyridoindoles
Current Medicinal Chemistry Editorial [Hot Topic: Frontotemporal Lobar Degeneration and Related Disorders (Guest Editor: Barbara Borroni)]
Current Alzheimer Research Therapeutic Challenges to Retinitis Pigmentosa: From Neuroprotection to Gene Therapy
Current Genomics